[Cirrhosis probably following ultra-virus hepatitis; retrocession of clinical manifestations and histological lesions after administration of aureomycin and terramycin].
D002690:Chlamydia Infections; D002751:Chlortetracycline / Q000627:therapeutic use*; D006505:Hepatitis; D006506:Hepatitis A / Q000150:complications*; D006518:Hepatitis Viruses; D008103:Liver Cirrhosis / Q000209:etiology*; D010118:Oxytetracycline / Q000627:therapeutic use*
D002751:Chlortetracycline; D010118:Oxytetracycline
AUREOMYCIN/therapeutic use; HEPATITIS, INFECTIOUS/complications; LIVER CIRRHOSIS/etiology and pathogenesis; OXYTETRACYCLINE/therapeutic use
Cirrhose vraisemblablement consécutive à une hépatite a ultra-virus; rétrocession des manifestations cliniques et des lésions histologiques après administration d'auréomycine et de terramycine.